Transformation

Thao Nguyen

Founder & CEO Equal Care

Biography

Thao Nguyen is the Founder and CEO of EQUAL CARE, a health technology company advancing sex- and gender-specific medicine through data, evidence, and AI. After more than a decade in MedTech and healthcare innovation, where she evaluated product portfolios and strategic investments, she founded EQUAL CARE to help close the gender health gap. Thao is a recognized voice in precision medicine, AI-enabled healthcare, and women’s health innovation, and regularly speaks on leadership, innovation, and evidence-based healthcare transformation.

Talk

From Project Killer to Founder: Leading Through the Tension of Knowing When to Stop

I spent 10 years in corporate reviewing MedTech projects and I killed 8 out of 10. Not because they weren’t interesting. But because they wouldn’t work. Today, as a founder, I face the same challenge from the other side. The biggest leadership gap I see, across corporate and startups, is not a lack of ideas. It’s the inability to stop. And stopping creates tension. Between logic and emotion. Between data and belief. Between what people have built and what the business actually needs. People don’t just work on projects, they defend them. Because stopping something challenges ego, ownership, and sunk cost. But in a world shaped by AI, speed, and constant disruption, holding on too long is often more dangerous than stopping too early. Leadership today means operating inside that tension—not avoiding it. It means making decisions when there is no perfect clarity. It means committing to assumptions, not to projects. And it means being willing to change direction the moment those assumptions no longer hold.

Thao shares what it takes to lead in that reality:

– Creating organisations where stopping is possible
– Normalising pivots without losing direction
– And making hard calls that others resist

Because leadership is not defined by what you build, but by how you navigate the tension of what to continue and what to stop.

Subscribe to our Newsletter to get 10% off your LEAD27 tickets